Mgr. Šárka Pavlová, Ph.D.
Assistant professor, Department of Internal Medicine, Hematology and Oncology
office: bldg. E35/258
Kamenice 753/5
625 00 Brno
| phone: | +420 549 49 5442 |
|---|---|
| e‑mail: |
| social and academic networks: |
|---|
Total number of publications: 201
2025
-
Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL
HemaSphere, year: 2025, volume: 9, edition: 1, DOI
-
Hypomethylating agents increase L1 retroelement expression without inducing novel insertions in myeloid malignancies
Molecular oncology, year: 2025, DOI
-
In-frame germline TP53 variant impairs p53 oligomerization and predisposes to cancer
Nature Scientific Reports, year: 2025, volume: 15, edition: 1, DOI
2024
-
Are del(17p) with concurrent TP53 mutation, and isolated TP53 mutation really equivalent?
Year: 2024, type: Conference abstract
-
Biomarker-guided treatment of CLL: where do we go from here?
Year: 2024, type: Requested lectures
-
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits
CELLULAR ONCOLOGY, year: 2024, volume: 47, edition: 6, DOI
-
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update
Leukemia, year: 2024, volume: 38, edition: 7, DOI
-
In-frame varianty genu TP53 nalezené v leukemických buňkách dospělých pacientů vedou ke ztrátě proteinu: mezinárodní studie
Year: 2024, type: Conference abstract
-
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients
British journal of haematology, year: 2024, volume: 204, edition: 1, DOI
-
KLONÁLNÍ KOMPETICE A ALTERACE MOLEKULÁRNÍCH DRAH U CHRONICKÉ LYMFOCYTÁRNÍ LEUKEMIE
Year: 2024, type: Conference abstract